[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100379202":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":47,"centralContacts":56,"locations":62,"responsibleParty":79,"collaborators":46,"id":82,"slug":83,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":46,"eligibilityCriteria":88,"healthyVolunteers":84,"sex":89,"minAge":46,"maxAge":46,"enrollmentInfo":90,"targetDuration":46,"studyType":93,"phases":94,"briefSummary":86,"conditions":96,"keywords":46,"overallStatus":65,"whyStopped":46,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"Tanta University","OTHER",[8,15,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard hydration alone","ACTIVE_COMPARATOR","Cisplatin with standard hydration",[13,14],"Other: Standard hydration","Drug: Cisplatin",{"label":16,"type":10,"description":17,"interventionNames":18},"Pantoprazole high dose","Cisplatin with standard hydration with pantoprazole 1.6 mg\u002Fkg",[19,13,14],"Drug: Pantoprazole high dose",{"label":21,"type":10,"description":22,"interventionNames":23},"Pantoprazole Low dose","Cisplatin with standard hydration with pantoprazole 0.6 mg\u002Fkg",[24,13,14],"Drug: Pantoprazole low dose",[26,33,38,43],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"DRUG","Pantoprazole low dose","Pantoprazole 0.6 mg\u002Fkg",[21],[32],"zurcal",{"type":27,"name":16,"description":34,"armGroupLabels":35,"otherNames":36},"Pantoprazole 1.6 mg\\\\kg",[16],[37],"zurcal, Controloc",{"type":6,"name":39,"description":9,"armGroupLabels":40,"otherNames":41},"Standard hydration",[21,16,9],[42],"Hydration",{"type":27,"name":44,"description":44,"armGroupLabels":45,"otherNames":46},"Cisplatin",[21,16,9],null,[48,52,54],{"name":49,"affiliation":50,"role":51},"Eman M Ghonaim, Msc","Demonstrator of Clinical Pharmacy","PRINCIPAL_INVESTIGATOR",{"name":53,"affiliation":5,"role":51},"Sahar El-Haggar, Prof",{"name":55,"affiliation":5,"role":51},"Suzy Goher, Lecturer",[57],{"name":58,"role":59,"phone":60,"phoneExt":46,"email":61},"Sherief Abd-Elsalam, ass. prof.","CONTACT","00201147773440","sheriefabdelsalam@yahoo.com",[63],{"facility":64,"status":65,"city":66,"state":46,"zip":46,"country":67,"countryCode":68,"cosmosGeoPoint":69,"geoPoint":74,"contacts":75},"Sherief Abd-Elsalam","RECRUITING","Tanta","Egypt","EG",{"type":70,"coordinates":71},"Point",[72,73],31.00192,30.78847,{"lat":73,"lon":72},[76],{"name":77,"role":59,"phone":78,"phoneExt":46,"email":61},"Sherief Abd-Elsalam, Ass. Prof.","00201009221243",{"type":80,"investigatorFullName":64,"investigatorTitle":81,"investigatorAffiliation":5,"oldNameTitle":46,"oldOrganization":46},"SPONSOR_INVESTIGATOR","Ass. Prof. Tropical Medicine","100379202","phase-3-pantoprazole-in-cisplatin-nephrotoxicity-100379202",false,"NCT04217512","Pantoprazole in Cisplatin Nephrotoxicity","Possible Protective Effect of Pantoprazole in Cisplatin Induced Nephrotoxicity in Patients With Head and Neck Cancer","Inclusion Criteria:\n\n* Patients with head and neck cancer\n\nExclusion Criteria:\n\n* GFR less than 59.\n* DM\n* Elevated liver enzymes more than 3 fold.","ALL",{"count":91,"type":92},60,"ESTIMATED","INTERVENTIONAL",[95],"PHASE3",[97],"Oncology","2020-01-02",{"date":100,"type":101},"2020-01-03","ACTUAL",{"date":103,"type":101},"2019-05-01",{"date":105,"type":92},"2030-12-30",{"name":64,"class":6},1]